"サノフィ" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonSanofi pipeline shines with multiple deals and clinical progress - Labiotech.eu
Sanofi pipeline shines with multiple deals and clinical progress Labiotech.eu
Sanofi’s Dupilumab Study: A Potential Game-Changer for Chronic Pruritus Treatment - TipRanks
Sanofi’s Dupilumab Study: A Potential Game-Changer for Chronic Pruritus Treatment TipRanks
Novavax Strengthens Position with Vaccine Approval and Sanofi Partnership - Yahoo Finance
Novavax Strengthens Position with Vaccine Approval and Sanofi Partnership Yahoo Finance
Sanofi receives orphan status from EMA for rilzabrutinib - Pharmaceutical Technology
Sanofi receives orphan status from EMA for rilzabrutinib Pharmaceutical Technology
What Recent Data Suggests About Sanofi’s Value After 6% Share Price Rise - simplywall.st
What Recent Data Suggests About Sanofi’s Value After 6% Share Price Rise simplywall.st
Digital and AI Powered Manufacturing & Supply: Delivering Faster and Safer for Patients - Sanofi
Digital and AI Powered Manufacturing & Supply: Delivering Faster and Safer for Patients Sanofi
Sanofi’s multiple myeloma candidate granted FDA orphan drug designation - PMLiVE
Sanofi’s multiple myeloma candidate granted FDA orphan drug designation PMLiVE
Fierce Pharma Asia—Sanofi pulls Praluent in China; Trump updates drug tariff threat; An early-sta...
Fierce Pharma Asia—Sanofi pulls Praluent in China; Trump updates drug tariff threat; An early-stage capital crunch Fierce Pharma
Sanofi pens $395M China pact for Arrowhead metabolic med awaiting approval decision - Fierce Biotech
Sanofi pens $395M China pact for Arrowhead metabolic med awaiting approval decision Fierce Biotech
Sanofi sees 'manageable' impact from US tariffs, expects strong sales growth - Reuters
Sanofi sees 'manageable' impact from US tariffs, expects strong sales growth Reuters
Sanofi’s Promising Phase 2a Diabetes Study: A Potential Game-Changer? - TipRanks
Sanofi’s Promising Phase 2a Diabetes Study: A Potential Game-Changer? TipRanks
Sanofi: Information concerning the total number of voting rights and shares - July 2025 - Yahoo F...
Sanofi: Information concerning the total number of voting rights and shares - July 2025 Yahoo Finance
Digital Transformation and Artificial Intelligence - Sanofi
Sanofi touts tariff resilience for rest of 2025 as CEO admits many unknowns persist - Fierce Pharma
Sanofi touts tariff resilience for rest of 2025 as CEO admits many unknowns persist Fierce Pharma
Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Prurigo Nodularis Treatment ...
Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Prurigo Nodularis Treatment TipRanks
Environmental Impact and Healthcare Systems’ Resilience - Sanofi
Environmental Impact and Healthcare Systems’ Resilience Sanofi
Sanofi’s Phase 3 Study on PCV21 Vaccine: A Potential Game-Changer in Pediatric Health - TipRanks
Sanofi’s Phase 3 Study on PCV21 Vaccine: A Potential Game-Changer in Pediatric Health TipRanks
Sanofi’s New Vaccine Trial: A Potential Game-Changer for Infant Health - TipRanks
Sanofi’s New Vaccine Trial: A Potential Game-Changer for Infant Health TipRanks
Sanofi’s Phase 3 Study on Riliprubart for CIDP: A Potential Game-Changer - TipRanks
Sanofi’s Phase 3 Study on Riliprubart for CIDP: A Potential Game-Changer TipRanks
Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Pediatric Prurigo Nodularis ...
Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Pediatric Prurigo Nodularis TipRanks
Regeneron and Sanofi’s Itepekimab Study: A Potential Game-Changer for COPD Treatment - TipRanks
Regeneron and Sanofi’s Itepekimab Study: A Potential Game-Changer for COPD Treatment TipRanks
Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces...
Regeneron and Sanofi’s Dupilumab Study: A Potential Game Changer for Chronic Urticaria - TipRanks
Regeneron and Sanofi’s Dupilumab Study: A Potential Game Changer for Chronic Urticaria TipRanks
Sustainability: Building a Healthier World - Sanofi
Don’t delegate the AI revolution: A conversation with Sanofi CEO Paul Hudson - McKinsey & Company
Don’t delegate the AI revolution: A conversation with Sanofi CEO Paul Hudson McKinsey & Company
Sanofi’s Phase 3 Study on PCV21 Vaccine: A Potential Game-Changer for Infant Immunization - TipRanks
Sanofi’s Phase 3 Study on PCV21 Vaccine: A Potential Game-Changer for Infant Immunization TipRanks
A New Era of Biopharma Production with AI - Sanofi
Sustainable and Equitable Access to Healthcare - Sanofi
Sanofi’s Phase 3 Study on Riliprubart: A Potential Game-Changer for CIDP Treatment - TipRanks
Sanofi’s Phase 3 Study on Riliprubart: A Potential Game-Changer for CIDP Treatment TipRanks
Sanofi’s SAR445877 Study: A Potential Breakthrough in Cancer Treatment - TipRanks
Sanofi’s SAR445877 Study: A Potential Breakthrough in Cancer Treatment TipRanks
Sanofi to acquire Blueprint for up to $9.5B - BioPharma Dive
Sanofi to acquire Blueprint for up to $9.5B BioPharma Dive
Weil Advises Sanofi in its $9.5 Billion Acquisition of Blueprint Medicines - Weil
Weil Advises Sanofi in its $9.5 Billion Acquisition of Blueprint Medicines Weil
France's Sanofi to acquire biotech firm Vicebio for $1.15 billion - Reuters
France's Sanofi to acquire biotech firm Vicebio for $1.15 billion Reuters
Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes - Pharmaceutical Technology
Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes Pharmaceutical Technology
Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline - Reuters
Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline Reuters
Sanofi to acquire vaccine biotech in billion-dollar deal - BioPharma Dive
Sanofi to acquire vaccine biotech in billion-dollar deal BioPharma Dive
Genomic Medicine Unit: Overcoming Gene Therapy’s Greatest Challenges - Sanofi
Genomic Medicine Unit: Overcoming Gene Therapy’s Greatest Challenges Sanofi
AI Across the R&D Value Chain: Drug Discovery - Sanofi
Transforming Regulatory Affairs l Sanofi - Sanofi
Sanofi exploring vaccine production in Vietnam with local partner - Reuters
Sanofi exploring vaccine production in Vietnam with local partner Reuters
Thermo Fisher acquires Sanofi's New Jersey manufacturing site - Reuters
Thermo Fisher acquires Sanofi's New Jersey manufacturing site Reuters
Tackling atopic dermatitis from all angles - Sanofi
Meet our A Million Conversations Advisory Group - Sanofi
Sanofi takes up option on Adagene bispecific and invests $25M, shielding partner from runway risk...
Sanofi takes up option on Adagene bispecific and invests $25M, shielding partner from runway risk Fierce Biotech
Press release: Online availability of Sanofi’s half-year financial report for 2025 - GlobeNewswire
Press release: Online availability of Sanofi’s half-year financial report for 2025 GlobeNewswire
US FDA approves use of Sanofi's meningococcal vaccine in infants - Reuters
US FDA approves use of Sanofi's meningococcal vaccine in infants Reuters
Breakingviews - Sanofi finds M&A fix for its multiple itches - Reuters
Breakingviews - Sanofi finds M&A fix for its multiple itches Reuters
CEO of pharma giant Sanofi says businesses should stop ‘AI washing’ - Fortune
CEO of pharma giant Sanofi says businesses should stop ‘AI washing’ Fortune
France's Sanofi to invest at least $20 billion in US through 2030 - Reuters
France's Sanofi to invest at least $20 billion in US through 2030 Reuters
Sanofi tightens grip on RSV, paying $1.15B upfront for Vicebio and boosting its pipeline beyond m...
Sanofi tightens grip on RSV, paying $1.15B upfront for Vicebio and boosting its pipeline beyond mRNA Fierce Biotech
Sanofi to buy Blueprint Medicines - Chemical & Engineering News
Sanofi to buy Blueprint Medicines Chemical & Engineering News
Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes - Yahoo Finance
Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes Yahoo Finance
Sanofi’s Tzield type 1 diabetes immunotherapy wins UK first - European Pharmaceutical Review
Sanofi’s Tzield type 1 diabetes immunotherapy wins UK first European Pharmaceutical Review
Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase - Fierce Pharma
Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase Fierce Pharma
Sanofi to buy US biopharma group Blueprint for up to $9.5 billion - Reuters
Sanofi to buy US biopharma group Blueprint for up to $9.5 billion Reuters
Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication - Fierce Biotech
Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication Fierce Biotech
NextGen Scholars: Shaping Future Healthcare Leaders - Sanofi
Sanofi hops on the US investment bandwagon with $20B commitment through 2030 - Fierce Pharma
Sanofi hops on the US investment bandwagon with $20B commitment through 2030 Fierce Pharma
The Continuous Push for Equity in the Rare Disease Community - Sanofi
The Continuous Push for Equity in the Rare Disease Community Sanofi
Sanofi to pour more than $20B into US drug research and manufacturing - BioPharma Dive
Sanofi to pour more than $20B into US drug research and manufacturing BioPharma Dive
Sanofi stays on course amid tariff turmoil - BioPharma Dive
Sanofi stays on course amid tariff turmoil BioPharma Dive
Fast-Tracking Hope: How Our Translational Medicine Team is Changing the Drug Development Game - S...
Fast-Tracking Hope: How Our Translational Medicine Team is Changing the Drug Development Game Sanofi
Gov. Murphy, Morristown welcome 2,000 Sanofi employees to new office building - Morris County NJ ...
Gov. Murphy, Morristown welcome 2,000 Sanofi employees to new office building Morris County NJ News | Daily Record
HRSA directs Sanofi to cease implementing unapproved 340B rebate proposal - American Hospital Ass...
HRSA directs Sanofi to cease implementing unapproved 340B rebate proposal American Hospital Association
Sanofi’s $130M Morristown flagship puts people first - NJBIZ
VICTORY — Global Healthcare Company Sanofi Walks Back Illegal, Discriminatory Hiring Practices Fo...
VICTORY — Global Healthcare Company Sanofi Walks Back Illegal, Discriminatory Hiring Practices Following Federal Civil Rights Complaint from America First Legal America First Legal
Sanofi opens doors to $130M 'flagship' US office facility in New Jersey - Fierce Pharma
Sanofi opens doors to $130M 'flagship' US office facility in New Jersey Fierce Pharma
Sanofi to buy Blueprint Medicines for over $9 billion - Chemistry World
Sanofi to buy Blueprint Medicines for over $9 billion Chemistry World
Sanofi to Acquire Blueprint Medicines for Up to $9.5B - Genetic Engineering and Biotechnology News
Sanofi to Acquire Blueprint Medicines for Up to $9.5B Genetic Engineering and Biotechnology News
Sanofi hands back cancer NK cell engager to Innate amid autoimmune pivot - Fierce Biotech
Sanofi hands back cancer NK cell engager to Innate amid autoimmune pivot Fierce Biotech
Sanofi backs $90M financing for I&I biologic developer - FirstWord Pharma
Sanofi backs $90M financing for I&I biologic developer FirstWord Pharma
Achieving R&D Excellence to Shape the Medicines of Tomorrow - Sanofi
Achieving R&D Excellence to Shape the Medicines of Tomorrow Sanofi
From Design to Manufacturing: Working as One Team to Bring Medicines to Patients Faster - Sanofi
From Design to Manufacturing: Working as One Team to Bring Medicines to Patients Faster Sanofi
Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines - Yahoo Finance
Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines Yahoo Finance
Sanofi and Regeneron's high-flying Dupixent on course for an 'inflection year' in COPD - Fierce P...
Sanofi and Regeneron's high-flying Dupixent on course for an 'inflection year' in COPD Fierce Pharma
Sanofi Cuts Off Antibody Partner, Forcing 80% Headcount Reduction at IGM - BioSpace
Sanofi Cuts Off Antibody Partner, Forcing 80% Headcount Reduction at IGM BioSpace
Sanofi Inks $9.5B Blueprint Buyout to Expand Rare Disease Portfolio - BioSpace
Sanofi Inks $9.5B Blueprint Buyout to Expand Rare Disease Portfolio BioSpace
With Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint for $9.1B - Fierce P...
With Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint for $9.1B Fierce Pharma
ASCO: Sanofi shows investigational Sarclisa SC, delivered by on-body device, measures up to its I...
ASCO: Sanofi shows investigational Sarclisa SC, delivered by on-body device, measures up to its IV formulation Fierce Pharma
Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged - Reuters
Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged Reuters
Sanofi axes development of oral TNF inhibitor as monotherapy following Phase II fail - Clinical T...
Sanofi axes development of oral TNF inhibitor as monotherapy following Phase II fail Clinical Trials Arena
Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals - Fierce Pharma
Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals Fierce Pharma
Feeling RSV heat from Merck, Sanofi lays out early supply plans for Beyfortus - Fierce Pharma
Feeling RSV heat from Merck, Sanofi lays out early supply plans for Beyfortus Fierce Pharma
Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid - Yahoo Finance
Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid Yahoo Finance
From Molecules to Medicines – A Journey Through CMC Development - Sanofi
From Molecules to Medicines – A Journey Through CMC Development Sanofi
Olympic flame-out: Sanofi scorched for giving Paris 2024 tickets to UK patients - Fierce Pharma
Olympic flame-out: Sanofi scorched for giving Paris 2024 tickets to UK patients Fierce Pharma
Sanofi to buy US blood disorder drugmaker for up to $9.5bn - Financial Times
Sanofi to buy US blood disorder drugmaker for up to $9.5bn Financial Times
Press Release: Sanofi completes acquisition of Blueprint Medicines - GlobeNewswire
Press Release: Sanofi completes acquisition of Blueprint Medicines GlobeNewswire
Celebrating Women in Science - Sanofi
Celebrating Women in Science Sanofi
Kymera suffers Sanofi setback but secures $750M Gilead deal - Fierce Biotech
Kymera suffers Sanofi setback but secures $750M Gilead deal Fierce Biotech
Press Release: Sanofi announces extension of Blueprint tender offer - Yahoo Finance
Press Release: Sanofi announces extension of Blueprint tender offer Yahoo Finance
Sanofi opens $130M corporate hub in New Jersey as part of $20B U.S. investment push - drugdiscove...
Sanofi opens $130M corporate hub in New Jersey as part of $20B U.S. investment push drugdiscoverytrends.com
Sanofi's high hopes for $1.1B Kymab anti-inflammatory drug dented after phase 2 asthma failure - ...
Sanofi's high hopes for $1.1B Kymab anti-inflammatory drug dented after phase 2 asthma failure Fierce Biotech
Sanofi pays $15M for another STAT6 degrader from fruitful Nurix collab - Fierce Biotech
Sanofi pays $15M for another STAT6 degrader from fruitful Nurix collab Fierce Biotech
Sanofi Makes $1.6B Vaccine Bet With Vicebio Acquisition - BioSpace
Sanofi Makes $1.6B Vaccine Bet With Vicebio Acquisition BioSpace
Press Release: Sanofi completes acquisition of DR-0201 - GlobeNewswire
Press Release: Sanofi completes acquisition of DR-0201 GlobeNewswire
Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label - Reuters
Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label Reuters
Sanofi signs up Chrissy Teigen for diabetes screening campaign - Fierce Pharma
Sanofi signs up Chrissy Teigen for diabetes screening campaign Fierce Pharma
Sanofi eyes vaccine manufacturing in Vietnam amid tech transfer with local firm - Fierce Pharma
Sanofi eyes vaccine manufacturing in Vietnam amid tech transfer with local firm Fierce Pharma
Sanofi: Information concerning the total number of voting rights and shares - June 2025 - GlobeNe...
Sanofi: Information concerning the total number of voting rights and shares - June 2025 GlobeNewswire